Back to Search

DEEANN REECE, MD

MD

Surgical Technologist

NPI: 1205823960Individual

Specialties, Licenses & Credentials

Obstetrics & Gynecology Physician

Obstetrics & Gynecology

Code: 207V00000X

35173(WI)
Surgical TechnologistPrimary

Specialist/Technologist, Other — Surgical Technologist

Code: 246ZS0410X

35173(WI)

Research & Publications (20)

1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
PMID 19448682·Bone Marrow Transplant·2010
8-other
The research mission in myeloma.
PMID 18685616·Leukemia·2009
8-other
Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant.
PMID 19450753·Biol Blood Marrow Transplant·2009
8-other
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
PMID 19170677·Br J Haematol·2009
3-trial
Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma.
PMID 19545290·Br J Haematol·2009
8-other
Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
PMID 18676019·Leuk Res·2009
8-other
Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study.
PMID 19498019·Blood·2009
3-trial
Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial.
PMID 19225538·Leukemia·2009
3-trial
Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant.
PMID 19322205·Leukemia·2009
4-observational
Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit.
PMID 18936734·Bone Marrow Transplant·2009
8-other
Prognostic relevance of 6q deletion in Waldenström's macroglobulinemia: a multicenter study.
PMID 19362968·Clin Lymphoma Myeloma·2009
4-observational
Recent trends in the management of newly diagnosed multiple myeloma.
PMID 19491669·Curr Opin Hematol·2009
6-review
Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13.
PMID 19332768·Blood·2009
3-trial
Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study.
PMID 18711175·J Clin Oncol·2008
3-trial
Comparison of twin and autologous transplants for multiple myeloma.
PMID 18804041·Biol Blood Marrow Transplant·2008
3-trial
A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma.
PMID 18381234·Cancer Treat Rev·2008
1-meta
Developing a senior healthcare practice using the chronic care model: effect on physical function and health-related quality of life.
PMID 18503521·J Am Geriatr Soc·2008
3-trial
Treatment of relapsed and refractory myeloma.
PMID 18608859·Leuk Lymphoma·2008
6-review
Phase I-II trial of bortezomib plus oral cyclophosphamide and prednisone in relapsed and refractory multiple myeloma.
PMID 18645194·J Clin Oncol·2008
3-trial
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.
PMID 18804043·Biol Blood Marrow Transplant·2008
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1501 S MADISON ST
APPLETON, WI 54915

Location

Practice Location

1501 S MADISON ST, APPLETON, WI
(920) 730-4435

Quick Facts

NPI
1205823960
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile